Objective: To examine the feasibility of using phylloquinone intake as a marker for coronary heart disease (CHD) and stroke risk in women. Design and setting: Nurses' Health Study, a prospective cohort study during 1984 -2000 . Dietary data were collected in 1984 , 1986 , 1990, and 1994 using a validated semiquantitative food frequency questionnaire. Subjects: A total of 72 874 female nurses, aged 38-65 y, without previously diagnosed angina, myocardial infarction (MI), stroke, or cancer at baseline. Main outcome measures: Incidence of nonfatal MI, CHD deaths, total CHD events, ischemic, and total strokes. Results: There were 1679 CHD events (1201 nonfatal) and 1009 strokes (567 ischemic). After adjustment for age and lifestyle factors associated with cardiovascular disease risk, the multivariate relative risks (RR) (95% CI) of total CHD from the lowest to the highest quintile category of phylloquinone intake were 1 (reference), 0.80 (0.69-0.94), 0.86 (0.74-1.00), 0.77 (0.66-0.99), and 0.79 (0.68-0.92), P for trend ¼ 0.01. Further adjustment for dietary intakes of saturated fat, polyunsaturated fat, trans fatty acids, eicosapentaenoic, and docosahexaenoic acids, cereal fiber, and folate attenuated the association (RR comparing extreme quintiles 0.84 [0.71-1.00], P for trend ¼ 0.12). Incidence rates of total or ischemic strokes were not associated with phylloquinone intake. Conclusion: The data suggest that high phylloquinone intake may be a marker for low CHD risk. Dietary and lifestyle patterns associated with phylloquinone intakes, rather than intake of the nutrient itself, might account for all or part of the weak association. Sponsorship:
Introduction
In Europe and North America, phylloquinone (vitamin K1) is primarily derived from green vegetables and some plant oils (Booth & Suttie, 1998) . Phylloquinone functions as a cofactor for the vitamin K-dependent carboxylase that facilitates formation of gamma-carboxyglutamyl (Gla) residues. These vitamin K-dependent proteins are involved in several biological functions, including blood coagulation, vascular calcification, and bone metabolism (Ferland, 1998) . Phylloquinone intakes are inversely associated with the risk of developing age-related chronic disorders, such as calcification of the abdominal aorta (Jie et al, 1995) and hip fracture (Feskanich et al, 1999; Booth et al, 2000) .
Diets rich in fruits and vegetables have been part of the Dietary Guidelines for Americans recommendations for decades, and more recently advocated by the American Heart Association to promote both general health and to decrease risk of coronary heart disease (CHD) (Dietary Guidelines Advisory Committee, 2000; Krauss et al, 2000) . Large-scale observational studies have reported associations between diets high in fruits and vegetables and decreased risk of cardiovascular disease and stroke (Gillman et al, 1995; Joshipura et al, 1999; Liu et al, 2000; Joshipura et al, 2001; Johnsen et al, 2003; Steffen et al, 2003) . The specific constituents responsible for the apparent inverse relationships with fruits and vegetables are not clear, although betacarotene by itself does not appear to be explanatory (Hennekens et al, 1996; Rapola et al, 1997; Lee et al, 1999) . Furthermore, the evidence on other antioxidants (vitamins E and C) does not support a beneficial effect on CHD risk (The Heart Outcomes Prevention Evaluation Study Investigators, 2000; Heart Protection Study Collaborative Group, 2002) .
Because foods containing high amounts of phylloquinone are limited to green vegetables, and because green vegetables are the major source of phylloquinone in Western diets, dietary phylloquinone intakes may be a useful indicator for the identification of individuals eating a diet consistent with current dietary recommendations and practicing healthy life-style behaviors. In support of this hypothesis, previous reports have suggested that higher intakes of green vegetables are associated with lower risk of CHD (Gaziano et al, 1995; Key et al, 1996; Cox et al, 2000; Joshipura et al, 2001) and stroke (Joshipura et al, 1999; Johnsen et al, 2003) . Alternatively, animal and molecular evidence suggests that vitamin K may play a direct protective role in the pathogenesis of coronary calcification, as well as osteoporosis (Shearer, 2000) . In humans, the evidence for a role of vitamin K in vascular calcification is limited to a single observational study in postmenopausal women (Jie et al, 1995) . Atherosclerosis-related mechanisms might be associated primarily with nonfatal CHD events, whereas fatal events can also involve arrhythmias. The aim of the present study was to examine prospectively the feasibility of using phylloquinone intake as a marker of CHD and stroke risk in the Nurses' Health Study.
Methods
The Nurses' Health Study was initiated in 1976 when 121 700 female registered nurses 30-55 y of age answered a mailed questionnaire on their medical history and lifestyle. A total of 81 757 women returned a valid diet questionnaire in 1984, which was used as a baseline. Women who had implausibly high (43500 kcal/day [414.64 MJ/day]) or low (o600 kcal/ day [o2.51 MJ/day]) energy intakes, or who left 470 food items blank were excluded. We also excluded women who reported a diagnosis of cancer (n ¼ 4458), angina pectoris, myocardial infarction (MI), or stroke (n ¼ 3177) before completion of the baseline dietary questionnaire. The final sample size used for these analyses was 72 874 women. The study was approved by the Institutional Review Boards at Tufts/New England Medical Center and Brigham and Women's Hospital.
Dietary assessment
Diet was assessed by using semiquantitative food frequency questionnaires (FFQ) that included approximately 130 foods in 1984, 1986, 1990, and 1994 . The initial 1980 FFQ, which contained only 60 food items, had fewer questions on the intake of vegetables, for example, lettuce was not included and therefore we did not use the 1980 dietary data. A detailed description of the dietary questionnaires and documentation of their reproducibility and validity have been published (Willett et al, 1985) . Daily nutrient intakes were calculated by multiplying the nutrient content per serving of each food by the reported frequency of consumption and summing over all foods. Use of multivitamin and oil supplements was estimated based on questions in the FFQ. This FFQ has been validated for phylloquinone intake using diet records (Feskanich et al, 1999) and serum phylloquinone concentrations (McKeown et al, 2002) . The phylloquinone contents of food items on the FFQ were obtained from the Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University (Booth et al, 1993 (Booth et al, , 1995 . The food items on the FFQ that contributed the most to the total phylloquinone intake were iceberg lettuce (20%), spinach (18%), broccoli (15%), cabbage (7%), romaine lettuce (6%), Brussels sprouts (5%) and kale, mustard, and chard greens (4%). Supplemental intake from multivitamin preparations contributed only 0.21% of the total intake; nevertheless, intake of phylloquinone in the current study includes both dietary and supplemental intake. The number of servings of phylloquinone-rich vegetables was computed by summing the servings of broccoli, Brussels sprouts, cabbage, iceberg lettuce, romaine lettuce, spinach, and kale. Servings of broccoli, Brussels sprouts, cabbage, cauliflower, and kale were included in the Brassica group.
Covariate measurement
The biennial mailed questionnaire collected information on several demographic, behavioral, and clinical variables. These included age, weight, height, current and previous smoking, menopausal status, use of hormone replacement therapy, history of hypertension, diabetes, and hypercholesterolemia, use of aspirin (based on questions on the frequency of use and dose when used), parental history of MI before or at 60 y of age. Body mass index (BMI), smoking status, menopausal status, and use of supplements were updated every 2 y until 1998. Aspirin use was assessed in 1984 and 1988. Physical activity was updated every 2 y until 1992.
Outcomes
The end point for this analysis was incidence of CHD (total and fatal CHD, and nonfatal MIs) and incidence of strokes (total and ischemic) that occurred after returning the 1984 questionnaires but before June 1, 2000. For each woman, only the first cardiovascular (CVD) event was considered. Women who reported a diagnosis of CHD or stroke in a biennial questionnaire were asked for permission to examine their medical records. Study physicians with no knowledge of the women's self-reported risk factor status reviewed the records to verify the occurrence of a CVD event. The diagnosis of MI was confirmed by using World Health Organization criteria (Rose & Blackburn, 1982) defined as symptoms, in addition to either diagnostic electrocardiographic changes or elevated cardiac enzyme levels. MIs that required hospital admission and for which confirmatory information was obtained by telephone interview or letter, but for which no medical records were available, were regarded as probable (28% of total CHD) and were included in the analyses. Fatal CHD was confirmed by hospital records, or by autopsy, or by evidence of previous CHD if CHD was listed as the cause of death on the death certificate. Strokes were verified against the criteria of the National Survey of Stroke (Walker et al, 1981) . When no medical records were available, strokes were confirmed by telephone interview or letter and were regarded as probable (26% of total strokes). Owing to differences in the cause between ischemic and hemorrhagic strokes, this report focused on ischemic strokes, which included cases of thrombotic and embolic strokes. For ischemic stroke, a definite diagnosis was made when computer tomographic scan, magnetic resonance imaging, angiography, surgery or autopsy confirmed the lesion, and if such information was lacking, a probable diagnosis was made. Deaths were reported by the women's next of kin or were obtained from postal authorities or from the National Death Index.
Statistical analyses
The person-time for each participant was calculated from the date of return of the 1984 questionnaire to the date of the first CVD event, death, or the cutoff date (June 1, 2000) . To reduce within-person variation in nutrient intakes and to better represent long-term diet, we applied a cumulative average method for nutrient intake and food consumption from all available FFQs from 1984 , 1986 , 1990 , and 1994 (Hu et al, 1997 . For example, the incidence of CHD from 1984 to 1986 was related to phylloquinone intake reported on the 1984 FFQ, and incidence from 1986 to 1988 was related to the average intake reported on the 1984 and 1986 FFQs.
Hazard ratios from Cox proportional hazards modeling were used to estimate relative risks (RR) and 95% confidence intervals (CI) of total CHD, fatal CHD, nonfatal MI, and total and ischemic stroke. Analyses were adjusted for self-reported covariates: age (in months), smoking (never, past, or current [1-14, 15-24, 424 cigarettes/day]), parental history of MI (r60 y of age), BMI (o22, , Z29 kg/m 2 ), moderate to vigorous physical activity (o1, 1-1.9, 2-3.9, 4-6.9, Z7 h/week), use of aspirin (o1, 1-2, 3-6, 7-14, Z15 tablets/week), alcohol intake (0, 0.1-4.9, 5.0-14.9, Z15 g/day), history of hypertension, hypercholesterolemia, or diabetes, use of multivitamin supplements, menopausal status and use of hormone replacement therapy (premenopausal, postmenopausal without hormone replacement, postmenopausal with past hormone replacement, postmenopausal with current hormone replacement). In multivariate models, dietary covariates included energy intake as a continuous variable and quintile categories of energyadjusted intakes using the Willett residual method of saturated fat, polyunsaturated fat, trans fatty acids, eicosapentaenoic plus docosahexaenoic acids (EPA þ DHA), cereal fiber, and total folate (Willett & Stampfer, 1986) . Furthermore, energy intake and quintile categories of food consumption (whole grain, fish, red meat, and fruit) were used as covariates. The proportionality of the hazards was tested by entering 'phylloquinone intake multiplied by age in months' or 'phylloquinone intake multiplied by time in study in 2-y intervals', and then both these interaction terms into the models. The results of these analyses indicated that the assumption of proportionality of the hazards was tenable. Tests of linear trend across increasing categories of phylloquinone intake or consumption of foods rich in phylloquinone were conducted using the same regression models described above by assigning the medians of intake/ consumption for each quintile category to everyone in the respective category. These new median intake variables were treated as continuous factors, and P value for the regression coefficient was reported to represent the significance of the linear trend across quintile categories. Because of possible changes in diet after diagnosis of diabetes, we performed secondary analyses excluding women who had reported having diabetes before 1984. The statistical analyses were done with SAS version 8.2 (SAS Institute Inc, Cary, NC, USA). Data are presented as means7s.d., unless otherwise stated. A value of Po0.05 (two-tailed) was considered statistically significant.
Results
During the 16 y follow-up from 1984 to 2000, we documented a total of 1679 cases of CHD, of which 1201 were nonfatal MIs; and 1009 strokes, of which 567 were ischemic strokes. Mean7s.d. (median) intake of phylloquinone in the women was 1847106 (163) mg/day. The distribution of baseline characteristics in quintile categories of phylloquinone intake is presented in Table 1 . The median phylloquinone intake ranged from 87 mg/day in the lowest quintile category to 300 mg/day in the highest quintile category. Women with high phylloquinone intake were more likely to be older, postmenopausal, physically active, smoke less and use multivitamin supplements more frequently. Self-re-ported hypertension and hypercholesterolemia were more common among those with high phylloquinone intake. High phylloquinone intake was associated with higher protein intake, derived either from animal or vegetable sources, and lower total, saturated, and monounsaturated fat and trans fatty acid intake when each was expressed as a percentage of energy intake (Table 1) . Phylloquinone intake was positively associated with fiber and whole-grain intakes. Phylloquinone and coronary heart disease AT Erkkilä et al
Intake of nutrients that are associated with high vegetable consumption, such as folate, vitamin C and beta-carotene, were higher in the subjects with high phylloquinone intake. Broccoli, Brussels sprouts, cabbage, kale, lettuce, and spinach are rich in phylloquinone, and the number of servings of these vegetables combined was positively associated with phylloquinone intake. Compared to women in the lowest quintile category of phylloquinone intake, there was a 23-33% lower ageadjusted risk of CHD in women in the highest four quintile categories of phylloquinone intake (Table 2) . After adjusting for lifestyle factors associated with risk of CVD (BMI, smoking, elevated blood pressure, diabetes, hypercholesterolemia, menopausal status, use of hormone replacement therapy, parental history of MI, physical activity, alcohol intake, and uses of aspirin and multivitamin supplements) the association remained significant (P for trend 0.01). Further adjustment for intakes of fatty acids, cereal fiber and folate, dietary factors previously reported to be related to CHD risk, attenuated the association (P for trend P ¼ 0.12). However, the risk in the second, fourth, and fifth quintile categories of phylloquinone intake remained significantly lower. With adjustment for lifestyle factors and dietary consumption of whole-grains, fish, red meat, and fruit the risk of CHD in the highest phylloquinone quintile category was 0.84 (95% CI 0.72-0.99, P for trend 0.12).
When CHD was classified as fatal and nonfatal, higher phylloquinone intake was associated with lower risk of nonfatal MI (multivariate model 1) ( Table 2 ). The risk of fatal CHD was not significantly associated with phylloquinone intake. In secondary analyses, we excluded women with self-reported diabetes at the baseline; associations between phylloquinone intake and risks of total and fatal CHD, and nonfatal MI remained unchanged (data not shown).
The women in the highest quintile category of phylloquinone-rich vegetables consumption had a 35% (95% CI 23-45%) lower age-adjusted risk of total CHD and 31% (95% CI 16-43%) lower risk of nonfatal CHD than the women in the lowest consumption quintile category (Table 3) . Adjustments for lifestyle factors and dietary intakes of fatty acids and cereal fiber attenuated the associations and the associations remained barely significant. Consumption of lettuce (iceberg and romaine combined), but not that of Brassica group vegetables, tended to be associated with lower risks of total CHD and nonfatal MI. After adjustments for lifestyle and nutrient factors, risk of fatal CHD was not significantly associated with consumption of phylloquinone-rich vegetables, Brassica vegetables, or lettuce.
Risk of total stroke was not associated with phylloquinone intake (Table 4) . Consistent with total stroke, the risk of ischemic stroke was not significantly associated with phylloquinone intake. Likewise, consumption of phylloquinonerich vegetables, vegetables from the Brassica group, or lettuce were not associated with risks of total or ischemic stroke (data not shown). BMI (o22, , Z29 kg/m 2 ), smoking (never, past, current [1-14, 15-24, Z25 cigarettes/day]), history of elevated blood pressure, history of elevated serum cholesterol, diabetes, menopausal status and use of hormone replacement therapy (premenopausal, postmenopausal without or with past/current hormone-replacement), parental history of MI (r60 y), moderate or vigorous physical activity (o1, 1-1.9, 2-3.9, 4-6.9, Z7 h/week), use of aspirin (o1, 1-2, 3-6, 7-14, and Z15 tablets/week), alcohol intake (0, 0.1-4.9, 5.0-14.9, Z15 g/day), and use of multivitamin supplements. b Adjusted for variables in multivariate model 1 þ energy intake, quintile categories of energy-adjusted intakes of saturated fat, polyunsaturated fat, EPA þ DHA, trans fatty acids, cereal fiber, and folate.
Discussion
The major finding of this study is that high phylloquinone intake is a marker for slightly reduced risks of total and nonfatal CHD, but not stroke. These inverse associations appeared to be independent of established CVD risk factors, such as smoking, hypercholesterolemia, and elevated blood pressure. However, these associations were attenuated after adjustment for dietary variables (energy-adjusted intakes of saturated fat, polyunsaturated fat, trans fat, EPA þ DHA, cereal fiber, and folate) previously shown to be related to BMI (o22, , Z29 kg/m 2 ), smoking (never, past, current [1-14, 15-24, Z25 cigarettes/day]), history of elevated blood pressure, history of elevated serum cholesterol, diabetes, menopausal status, and use of hormone replacement therapy (premenopausal, postmenopausal without or with past/current hormone replacement), parental history of MI (r60 y), moderate or vigorous physical activity (o1, 1-1.9, 2-3.9, 4-6.9, Z7 h/week), use of aspirin (o1, 1-2, 3-6, 7-14, and Z15 tablets/week), alcohol intake (0, 0.1-4.9, 5.0-14.9, Z15 g/day), and use of multivitamin supplements, energy intake, quintile categories of energy-adjusted intakes of saturated fat, polyunsaturated fat, EPA þ DHA, trans fatty acids, and cereal fiber. CHD both in observational and intervention studies (KrisEtherton & Yu, 1997; Rimm et al, 1998; GISSI-Prevenzione investigators, 1999; Wolk et al, 1999) . These data suggest that dietary patterns associated with high phylloquinone intake, rather that intake of the nutrient itself, may have accounted for this weak association with CHD risk.
To our knowledge, there are no published data specifically focused on phylloquinone intake and risk of CHD from cohort studies. Phylloquinone has a potential role in bone formation (Ferland, 1998) and calcification of the vessel walls (Jie et al, 1995; Vermeer & Braam, 2001 ). The vitamin Kdependent protein, matrix Gla protein (MGP) has been identified in atherosclerotic plaques (Dhore et al, 2001) . It has been hypothesized that vitamin K deficiency could lead to synthesis of undercarboxylated MGP, which can no longer function in inhibiting tissue calcification, thus increasing the risk of vascular calcification (Vermeer & Braam, 2001 ). Jie et al have reported in a population-based study of postmenopausal women that those with calcified lesions had lower intakes of phylloquinone and impaired vitamin K status than those without lesions (Jie et al, 1995) . Vitamin K antagonists, such as warfarin, accelerate calcification of arteries in rat models (Price et al, 2000) , whereas there are no comparable data currently available in humans. In the present study, the phylloquinone intake was inversely associated with nonfatal MI, which might be primarily associated with atherosclerosis-related mechanisms. However, the present results should be interpreted cautiously.
Instead of having an independent protective effect on CHD, high phylloquinone intake is more likely to be a marker of a healthy diet and lifestyle. The women who had the highest intake of phylloquinone had a generally healthier diet, such as lower intakes of saturated fat and trans fat and higher consumption of whole-grains and fruits.
They were also more often physically active, nonsmokers and users of multivitamin supplements. In support of this alternative explanation, the association between phylloquinone and CHD risk was attenuated to nonsignificant after adjustment for dietary intakes of fatty acids, cereal fiber, and folate. Folate was included in the model, as it is relatively high in vegetables and has likewise been inversely associated with CHD risk (Rimm et al, 1998) . Despite careful adjustment for potential dietary and lifestyle confounding variables, the possibility of unmeasured or incompletely controlled confounding cannot be excluded. Women with high phylloquinone intakes were older and reported high rates of CHD risk factors, such as diabetes, which could have introduced changes in their dietary habits. However, the association between phylloquinone intake and CHD risk remained significant after excluding diabetic women from the analyses. Although the definition of MI has changed over time, definition of MI used in the study is based on WHO definition in 1982 and has not changed. However, the introduction of new tests for cardiac enzymes in clinical practice to define MI may have aided smaller and milder MIs to have been defined as MIs (Luepker et al, 2003) .
In addition to a significant association between total phylloquinone intake and CHD risk, the number of servings of phylloquinone-rich vegetables was also inversely associated with the risk of CHD in this study. Vegetables belonging to the Brassica group, with the exception of cauliflower, have a high content of phylloquinone, but they were not associated with the risk of CHD. Consumption of green leafy vegetables, the major source of phylloquinone in European and North American diets (Booth & Suttie, 1998) , has been associated with lower morbidity and mortality from cardiovascular diseases in many (Gaziano et al, 1995; Key et al, 1996; Cox et al, 2000; Joshipura et al, 2001 ), but not in BMI (o22, , Z29 kg/m 2 ), smoking (never, past, current [1-14, 15-24, Z25 cigarettes/day]), history of elevated blood pressure, history of elevated serum cholesterol, diabetes, menopausal status and use of hormone replacement therapy (premenopausal, postmenopausal without or with past/current hormone replacement), parental history of MI (r60 y), moderate or vigorous physical activity (o1, 1-1.9, 2-3.9, 4-6.9, Z7 h/week), use of aspirin (o1, 1-2, 3-6, 7-14, and Z15 tablets/week), alcohol intake (0, 0.1-4.9, 5.0-14.9, Z15 g/day), and use of multivitamin supplements. b Adjusted for variables in multivariate model 1 þ energy intake, quintile categories of energy-adjusted intakes of saturated fat, polyunsaturated fat, EPA þ DHA, trans fatty acids, cereal fiber, and folate.
all studies (Mann et al, 1997) . These data suggest that the association between green leafy vegetables and CHD cannot be explained by high content of phylloquinone alone, but probably by combinations of multiple nutrients and phytochemicals in these foods. Furthermore, dietary and lifestyle patterns associated with high vegetable consumption may partly account for the lower risk.
The risk of CHD was lower in the second quintile category of phylloquinone intake compared to the first quintile category, and further risk reduction with increasing phylloquinone intakes was minimal. This suggests a threshold effect, with only the lowest intakes predisposing to higher risk. More than half of the women in the lowest quintile category reported usual phylloquinone intakes below the adequate intake (AI), 90 mg/day for women (Food and Nutrition Board, Institute of Medicine, 2001) . Because this FFQ may overestimate absolute phylloquinone intakes (Feskanich et al, 1999) , it is plausible that the majority of women in this quintile category had usual intakes below the AI. Metabolic data suggest that intakes o100 mg/day do not maximally support carboxylation of osteocalcin, which is a sensitive marker of phylloquinone status . In contrast, plasma phylloquinone reaches a plateau when dietary intakes of phylloquinone estimated by this FFQ exceed 200 mg/day (McKeown et al, 2002) . Current data are, however, limited and while this FFQ appears to be appropriate for ranking individuals across the entire range of intake, there could be limitations in estimating high phylloquinone intakes (Feskanich et al, 1999; McKeown et al, 2002) , which may have attenuated any linear trends.
Our results do not indicate an association between phylloquinone intake and risks of total and ischemic strokes. Generally, risk of stroke has not been as strongly associated with dietary and lifestyle factors as has risk of CHD, despite the association of incidence of stroke with hypertension and serum lipid abnormalities (Leys et al, 2002) . Some studies have reported lower risk of ischemic stroke with higher consumption of green leafy vegetables (Joshipura et al, 1999; Johnsen et al, 2003; Sauvaget et al, 2003) or with higher consumption of total vegetables (Hirvonen et al, 2000) . However, this association has not always been independent of known CVD risk factors (Johnsen et al, 2003) . An association between risk of total stroke and consumption of total vegetable or salad greens has not been confirmed (Gillman et al, 1995; Keli et al, 1996; Key et al, 1996; Joshipura et al, 1999; Johnsen et al, 2003) . Again, the lower risk of stroke associated with green vegetables in some of the studies could be related to combinations of multiple nutrients and phytochemicals in these foods, or they could be a reflection of healthy diets and lifestyles in general.
Our results suggest that high dietary intake of phylloquinone, the major source being green vegetables, is a marker for reduced CHD risk. Because there is a weak association that is further attenuated with adjustment for dietary factors associated with CHD risk, dietary and lifestyle patterns associated with phylloquinone intakes, rather than the nutrient itself, may account for all or part of the association. Risk of stroke is not associated with phylloquinone intake.
